NCT00318149View on ClinicalTrials.gov

Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population

PHASE2CompletedINTERVENTIONAL
Enrollment

425

Participants

Timeline

Start Date

October 10, 2005

Primary Completion Date

May 14, 2006

Study Completion Date

May 14, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Fluarix

1 dose administered intramuscularly in the deltoid region of the non-dominant arm

BIOLOGICAL

Fluarix-AS25

1 dose administered intramuscularly into the deltoid region of the non-dominant arm

BIOLOGICAL

Fluarix-AS50

1 dose administered intramuscularly into the deltoid region of the non-dominant arm

BIOLOGICAL

Fluarix-AS01B

1 dose administered intramuscularly into the deltoid region of the non-dominant arm

BIOLOGICAL

Fluarix-AS01E

1 dose administered intramuscularly into the deltoid region of the non-dominant arm

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY